RT Hero Placheolder
RT Hero Placheolder

This activity is supported by an independent educational grant from EyePoint Pharmaceuticals.

March 2026 Supplement | Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease

Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease